STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
AUCKLAND,New Zealand,March 4,2025-- Bizcap,a leading provider of fast,flexible business loans,has announced Bizcap Prime Loans,a new financing solution designed to provide longer-term,lower-rate fundi
Celebrate Raya with daily free shipping,exciting deals and cashback giveaways from Taobao KUALA LUMPUR,Malaysia,March 4,2025--Taobao Malaysia is ushering in its first-ever sales campaign dedicated to
New service streamlines RCS operations,enhances monetization,and simplifies financial management for telcos.
SINGAPORE,March 4,2025-- Giift,a leading global AI-powered loyalty and rewards SaaS commerce venture backed by Apis Partners,today announced its global rebranding to Xoxoday (pronounced as Zozoday).
IFS appoints Hannes Liebe as President,APJMEA DUBAI,UAE,March 4,2025-- IFS,the leading provider of enterprise cloud and Industrial AI software,announces the appointment ofHannes Liebe as the new Presi
BARCELONA,Spain,March 4,2025-- ZTE Corporation (0763.HK/000063.SZ),a global leading provider of integrated information and communication technology solutions,has unveiled its latest gaming smartphone
BEIJING,March 4,2025-- Jianzhi Education Technology Group Company Limited (the "Company" or "Jianzhi") (NASDAQ: JZ),a leading provider of digital educational content in China,today
FormerJPMorgan Chase and American Express executive brings over two decades of product and commercial leadership to loyalty-as-a-service company
BEIJING,March 5,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)),("Baidu" or the "Company"),a leading AI company with strong Internet foundatio
03-12
03-12
03-12
03-12
03-12
03-12
03-12
03-12
03-12
03-12
